Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 337

1.

Key ^{19}Ne States Identified Affecting γ-Ray Emission from ^{18}F in Novae.

Hall MR, Bardayan DW, Baugher T, Lepailleur A, Pain SD, Ratkiewicz A, Ahn S, Allen JM, Anderson JT, Ayangeakaa AD, Blackmon JC, Burcher S, Carpenter MP, Cha SM, Chae KY, Chipps KA, Cizewski JA, Febbraro M, Hall O, Hu J, Jiang CL, Jones KL, Lee EJ, O'Malley PD, Ota S, Rasco BC, Santiago-Gonzalez D, Seweryniak D, Sims H, Smith K, Tan WP, Thompson P, Thornsberry C, Varner RL, Walter D, Wilson GL, Zhu S.

Phys Rev Lett. 2019 Feb 8;122(5):052701. doi: 10.1103/PhysRevLett.122.052701.

PMID:
30822026
2.

Evaluating the in vitro susceptibility of bovine mastitis pathogens to a combination of kanamycin and cefalexin: Recommendations for a disk diffusion test.

Pillar CM, Goby L, Draghi D, Grover P, Thornsberry C.

J Dairy Sci. 2009 Dec;92(12):6217-27. doi: 10.3168/jds.2009-2282.

3.

Antimicrobial activity among multidrug-resistant Streptococcus pneumoniae isolated in the United States, 2001-2005.

Thornsberry C, Brown NP, Draghi DC, Evangelista AT, Yee YC, Sahm DF.

Postgrad Med. 2008 Sep;120(3 Suppl 1):32-8. doi: 10.3810/pgm.2008.09.suppl52.282.

PMID:
18931469
4.

Antimicrobial susceptibility profiles among common respiratory tract pathogens: a GLOBAL perspective.

Sahm DF, Brown NP, Thornsberry C, Jones ME.

Postgrad Med. 2008 Sep;120(3 Suppl 1):16-24. doi: 10.3810/pgm.2008.09.suppl52.280.

PMID:
18931467
5.

Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST Surveillance Initiative, 2001-2005.

Sahm DF, Brown NP, Draghi DC, Evangelista AT, Yee YC, Thornsberry C.

Postgrad Med. 2008 Sep;120(3 Suppl 1):8-15. doi: 10.3810/pgm.2008.09.suppl52.279.

PMID:
18931466
6.

Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.

Draghi DC, Benton BM, Krause KM, Thornsberry C, Pillar C, Sahm DF.

Antimicrob Agents Chemother. 2008 Jul;52(7):2383-8. doi: 10.1128/AAC.01641-07. Epub 2008 Apr 28.

7.

In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative.

Draghi DC, Benton BM, Krause KM, Thornsberry C, Pillar C, Sahm DF.

J Antimicrob Chemother. 2008 Jul;62(1):116-21. doi: 10.1093/jac/dkn124. Epub 2008 Apr 19.

PMID:
18424792
8.

Antimicrobial resistance trends among sinus isolates of Streptococcus pneumoniae in the United States (2001-2005).

Sahm DF, Benninger MS, Evangelista AT, Yee YC, Thornsberry C, Brown NP.

Otolaryngol Head Neck Surg. 2007 Mar;136(3):385-9.

PMID:
17321864
9.

Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studies.

Karlowsky JA, Jones ME, Thornsberry C, Evangelista AT, Yee YC, Sahm DF.

Clin Infect Dis. 2005 Feb 15;40 Suppl 2:S89-98.

PMID:
15712102
10.

Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002).

Jones ME, Draghi DC, Thornsberry C, Karlowsky JA, Sahm DF, Wenzel RP.

Ann Clin Microbiol Antimicrob. 2004 Jul 29;3:14.

11.

Development of a standardized susceptibility test for campylobacter with quality-control ranges for ciprofloxacin, doxycycline, erythromycin, gentamicin, and meropenem.

McDermott PF, Bodeis SM, Aarestrup FM, Brown S, Traczewski M, Fedorka-Cray P, Wallace M, Critchley IA, Thornsberry C, Graff S, Flamm R, Beyer J, Shortridge D, Piddock LJ, Ricci V, Johnson MM, Jones RN, Reller B, Mirrett S, Aldrobi J, Rennie R, Brosnikoff C, Turnbull L, Stein G, Schooley S, Hanson RA, Walker RD.

Microb Drug Resist. 2004 Summer;10(2):124-31.

PMID:
15256027
12.

Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002.

Flamm RK, Weaver MK, Thornsberry C, Jones ME, Karlowsky JA, Sahm DF.

Antimicrob Agents Chemother. 2004 Jul;48(7):2431-6.

13.

Antimicrobial susceptibility to levofloxacin and other antibacterial agents among common respiratory pathogens-a Brazilian perspective from the GLOBAL Surveillance Initiative 2001-2002.

Mendes C, Kiffer CR, Blosser-Middleton RS, Jones ME, Karlowsky JA, Barth A, Rossi F, Andrade S, Sader HS, Thornsberry C, Sahm DF; GLOBAL Surveillance Initiative 2001-2002.

Clin Microbiol Infect. 2004 Jun;10(6):521-6.

14.

Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapy.

Jones ME, Karlowsky JA, Draghi DC, Thornsberry C, Sahm DF, Nathwani D.

Int J Antimicrob Agents. 2004 Mar;23(3):240-6.

PMID:
15164964
15.

Rates of antimicrobial resistance among common bacterial pathogens causing respiratory, blood, urine, and skin and soft tissue infections in pediatric patients.

Jones ME, Karlowsky JA, Draghi DC, Thornsberry C, Sahm DF, Bradley JS.

Eur J Clin Microbiol Infect Dis. 2004 Jun;23(6):445-55. Epub 2004 May 20.

PMID:
15156358
16.

Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002.

Karlowsky JA, Jones ME, Draghi DC, Thornsberry C, Sahm DF, Volturo GA.

Ann Clin Microbiol Antimicrob. 2004 May 10;3:7.

17.

Factors influencing fluoroquinolone resistance.

Sahm DF, Thornsberry C, Jones ME, Karlowsky JA.

Emerg Infect Dis. 2003 Dec;9(12):1651-4. No abstract available.

19.

The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002.

Jones ME, Blosser-Middleton RS, Thornsberry C, Karlowsky JA, Sahm DF.

Diagn Microbiol Infect Dis. 2003 Dec;47(4):579-86.

PMID:
14711479
20.

Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy.

Jones ME, Karlowsky JA, Draghi DC, Thornsberry C, Sahm DF, Nathwani D.

Int J Antimicrob Agents. 2003 Oct;22(4):406-19.

PMID:
14522104
22.

In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000-2001.

Jones ME, Blosser-Middleton RS, Critchley IA, Karlowsky JA, Thornsberry C, Sahm DF.

Clin Microbiol Infect. 2003 Jul;9(7):590-9.

23.

Antimicrobial susceptibility of 840 clinical isolates of Haemophilus influenzae collected in four European countries in 2000-2001.

Blosser-Middleton R, Sahm DF, Thornsberry C, Jones ME, Hogan PA, Critchley IA, Karlowsky JA.

Clin Microbiol Infect. 2003 May;9(5):431-6.

25.
26.

Baseline study to determine in vitro activities of daptomycin against gram-positive pathogens isolated in the United States in 2000-2001.

Critchley IA, Blosser-Middleton RS, Jones ME, Thornsberry C, Sahm DF, Karlowsky JA.

Antimicrob Agents Chemother. 2003 May;47(5):1689-93.

27.
28.

Trends in antimicrobial susceptibilities among Enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001.

Karlowsky JA, Jones ME, Thornsberry C, Friedland IR, Sahm DF.

Antimicrob Agents Chemother. 2003 May;47(5):1672-80.

29.

Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002).

Karlowsky JA, Thornsberry C, Jones ME, Evangelista AT, Critchley IA, Sahm DF; TRUST Surveillance Program.

Clin Infect Dis. 2003 Apr 15;36(8):963-70. Epub 2003 Apr 2.

PMID:
12684907
30.

The application of information technology to regional, national, and global surveillance of antimicrobial resistance.

Sahm DF, Thornsberry C, Karlowsky JA.

Curr Pharm Des. 2003;9(12):969-74. Review.

PMID:
12678862
31.

Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001.

Critchley IA, Draghi DC, Sahm DF, Thornsberry C, Jones ME, Karlowsky JA.

J Antimicrob Chemother. 2003 Mar;51(3):639-49.

PMID:
12615866
32.

Reinterpretation of susceptibility data using current NCCLS breakpoint criteria.

Jones ME, Karlowsky JA, Blosser-Middleton R, Critchley I, Karginova E, Thornsberry C, Sahm DF.

Antimicrob Agents Chemother. 2003 Feb;47(2):830. No abstract available.

33.

Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.

Karlowsky JA, Thornsberry C, Jones ME, Sahm DF.

Clin Infect Dis. 2003 Jan 15;36(2):183-7. Epub 2003 Jan 3.

PMID:
12522750
34.

Activity of faropenem, a new furanem, against European respiratory pathogens collected during 2000-2001: a comparison with other beta-lactam agents.

Jones ME, Blosser-Middleton RS, Critchley IA, Karlowsky JA, Thornsberry C, Sahm DF.

J Antimicrob Chemother. 2003 Jan;51(1):196-9. No abstract available.

PMID:
12493818
35.

The activity of levofloxacin and comparator agents against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999 and 2000.

Jones ME, Blosser-Middleton RS, Critchley IA, Thornsberry C, Sahm DF, Yamakita J, Akasaki M, Karlowsky JA.

Chemotherapy. 2002 Dec;48(5):232-7.

PMID:
12476039
36.

Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle.

Mills O Jr, Thornsberry C, Cardin CW, Smiles KA, Leyden JJ.

Acta Derm Venereol. 2002;82(4):260-5.

37.

Phenotypic and genotypic analysis of levofloxacin-resistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999-2000.

Critchley IA, Blosser-Middleton RS, Jones ME, Karlowsky JA, Karginova EA, Thornsberry C, Sahm DF.

Int J Antimicrob Agents. 2002 Aug;20(2):100-7.

PMID:
12297358
38.

Antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in two successive respiratory seasons in the US.

Karlowsky JA, Draghi DC, Thornsberry C, Jones ME, Critchley IA, Sahm DF.

Int J Antimicrob Agents. 2002 Aug;20(2):76-85.

PMID:
12297355
39.

Relationship between antibiotic resistance in Streptococcus pneumoniae and that in Haemophilus influenzae: evidence for common selective pressure.

Jones ME, Karlowsky JA, Blosser-Middleton R, Critchley I, Thornsberry C, Sahm DF.

Antimicrob Agents Chemother. 2002 Sep;46(9):3106-7. No abstract available.

40.

Prevalence of oxacillin resistance in Staphylococcus aureus among inpatients and outpatients in the United States during 2000.

Jones ME, Mayfield DC, Thornsberry C, Karlowsky JA, Sahm DF, Peterson D.

Antimicrob Agents Chemother. 2002 Sep;46(9):3104-5. No abstract available.

41.

Longitudinal assessment of antipneumococcal susceptibility in the United States.

Jones ME, Karlowsky JA, Blosser-Middleton R, Critchley IA, Karginova E, Thornsberry C, Sahm DF.

Antimicrob Agents Chemother. 2002 Aug;46(8):2651-5.

42.

Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States.

Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF.

Antimicrob Agents Chemother. 2002 Aug;46(8):2540-5.

43.

In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe.

Critchley IA, Jones ME, Heinze PD, Hubbard D, Engler HD, Evangelista AT, Thornsberry C, Karlowsky JA, Sahm DF.

Clin Microbiol Infect. 2002 Apr;8(4):214-21.

44.

Determining Linezolid's baseline in vitro activity in Canada using gram-positive clinical isolates collected prior to its national release.

Karlowsky JA, Kelly LJ, Critchley IA, Jones ME, Thornsberry C, Sahm DF.

Antimicrob Agents Chemother. 2002 Jun;46(6):1989-92.

45.
46.

Antimicrobial resistance among respiratory pathogens collected in Thailand during 1999-2000.

Critchley IA, Blosser-Middleton R, Jones ME, Yamakita J, Aswapokee N, Chayakul P, Tharavichitukul P, Vibhagool A, Thornsberry C, Karlowsky JA, Sahm DF.

J Chemother. 2002 Apr;14(2):147-54.

PMID:
12017369
47.
48.

Antimicrobial resistance in respiratory pathogens isolated in Brazil during 1999-2000.

Critchley IA, Blosser RS, Karlowsky JA, Yamakita J, Barth A, Sader HS, Mendes C, Teixeira L, Rossi F, Dias CA, Jones ME, Thornsberry C, Sahm DF.

Braz J Infect Dis. 2001 Dec;5(6):294-304. Epub 2003 Feb 21.

PMID:
11980591
49.

Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a beta-lactamase-negative and ampicillin-resistant strain.

Karlowsky JA, Critchley IA, Blosser-Middleton RS, Karginova EA, Jones ME, Thornsberry C, Sahm DF.

J Clin Microbiol. 2002 Mar;40(3):1063-6.

50.

Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections: United States LIBRA surveillance data from 1999.

Critchley IA, Sahm DF, Thornsberry C, Blosser-Middleton RS, Jones ME, Karlowsky JA.

Diagn Microbiol Infect Dis. 2002 Feb;42(2):129-35.

PMID:
11858909

Supplemental Content

Loading ...
Support Center